These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 5090059
1. Effect of lipids on growth hormone secretion in humans. Blackard WG, Hull EW, Lopez A. J Clin Invest; 1971 Jul; 50(7):1439-43. PubMed ID: 5090059 [Abstract] [Full Text] [Related]
9. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. Gerich JE, Langlois M, Schneider V, Karam JH, Noacco C. J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225 [Abstract] [Full Text] [Related]
10. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M. J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263 [Abstract] [Full Text] [Related]
11. Glucagon-initiated human growth hormone release: a comparative study. Cain JP, Williams GH, Dluhy RG. Can Med Assoc J; 1972 Oct 07; 107(7):617-22. PubMed ID: 4665093 [Abstract] [Full Text] [Related]
13. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U. Exp Clin Endocrinol Diabetes; 2003 Aug 07; 111(5):246-50. PubMed ID: 12951628 [Abstract] [Full Text] [Related]
14. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients. Hansen AP, Christensen SE, Lundbaek K. Scand J Clin Lab Invest; 1975 May 07; 35(3):205-10. PubMed ID: 1153917 [Abstract] [Full Text] [Related]
15. Chronobiological pattern of growth hormone secretion in normal subjects and in retinopathic diabetics. Lack of suppression by a plurichronocorticoid drug. Muggeo M, Molinari M, Baiocchi A, Tiengo A, Fedele D, Crepaldi G. Chronobiologia; 1976 May 07; 3(4):323-34. PubMed ID: 1030662 [Abstract] [Full Text] [Related]
16. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Carpentier AC, Frisch F, Cyr D, Généreux P, Patterson BW, Giguère R, Baillargeon JP. Am J Physiol Endocrinol Metab; 2005 Nov 07; 289(5):E849-56. PubMed ID: 15972273 [Abstract] [Full Text] [Related]
18. [The effect of an infusion of glucose-insulin-potassium and of heparin on the plasma free fatty acid levels and on blood glucose]. Haslauer F, Krempler F, Bolzano K, Sandhofer F. Wien Klin Wochenschr; 1983 Sep 16; 95(17):618-21. PubMed ID: 6359725 [Abstract] [Full Text] [Related]
19. [Somatotropin secretion stimulation test for diencephalic and pituitary diseases, with special reference to the tests using arginine and insulin]. Nakagawa K, Okamoto M, Horiuchi Y, Mashimo K. Saishin Igaku; 1969 Nov 16; 24(11):2333-9. PubMed ID: 5359819 [No Abstract] [Full Text] [Related]
20. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man. Abrams RL, Grumbach MM, Kaplan SL. J Clin Invest; 1971 Apr 16; 50(4):940-50. PubMed ID: 4926262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]